Use access key #2 to skip to page content.
$49.20 0.80 (1.65%)
1/7/2009 4:02 PM

Quest Diagnostics, Inc. (DGX)

CAPS Rating:
****

A provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health.

View All Commentary (DGX)

Recs

1

Avatar aitraders (< 20) Submitted: 1/31/08 2:26 PM : Outperform Start Price: $48.93 DGX Score: 34.33

Exorcised UNH, assimilated Ameripath, mid-year guidance of 6.1 to 6.2 B for 2007 will end up at 6.6/6.7, operating margins are going back up, Ameripath should fuel growth for 2008 and beyond, and now, I've read that the sales reps can now concentrate on new business, instead of keeping old.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links